Why Humana Inc. (HUM) stock moved
Humana Inc. (HUM) shares fell 0.4% to $398.25 as of July 21, 2026, a slight decline from the prior close of $400.00. BestStocks flagged the session as a material change for HUM. No single company-specific catalyst was confirmed during the move window. Below, we break down what changed for HUM, why it matters for investors, how the stock reacted, and the catalysts on the calendar.
HUM fell 0.4% to $398.25
HUM fell 0.4% in its latest session, moving from $400.00 to $398.25.
What it means for Humana Inc. investors
For Humana Inc. investors, the recent signals are mixed, leaving the near-term picture neutral / mixed. On the constructive side: Humana Inc. (HUM) moved +3.50% from $386.48 to $400.00 on 2026-07-17; Humana Inc. (HUM) moved +3.51% from $392.22 to $406.00 on 2026-07-13. Weighing against that: Negative session, down 0.4%; Humana Inc. (HUM) moved -5.22% from $407.78 to $386.48 on 2026-07-16. Wall Street's consensus price target sits at $343.06, implying -13.9% downside from $398.25. Over the past 90 days analysts logged 2 upgrades and 0 downgrades. BestStocks rates the overall signal quality weak (0/100). With earnings roughly 8 days out, the next report is the most likely near-term test of the move.
HUM price reaction
HUM last traded at $398.25, down $1.75 (-0.44%) from the previous close of $400.00. The session traded on 0.4× average volume (below avg), so participation was unremarkable. Over the past month the stock has ranged between $359.13 and $409.42, and it currently sits about 78% of the way up that band.
Bullish and bearish analyst opinions on Humana Inc. (HUM)
The consensus analyst price target on Humana Inc. (HUM) is $343.06, 13.9% below the recent $398.25. Over the past 90 days analysts logged 2 upgrades, 24 maintains, and 0 downgrades. Here is how the bullish and bearish cases on HUM line up.
The bullish case
- The Street's most bullish target is $502.00 (+26.1%).
- 2 analyst upgrades in the past 90 days, most recently Wells Fargo to Overweight (2026-07-13).
- Humana Inc. (HUM) moved +3.50% from $386.48 to $400.00 on 2026-07-17.
- Positive price momentum.
The bearish case
- The consensus analyst price target of $343.06 sits 13.9% below the recent $398.25, so the average target sees limited room to run.
- The most bearish analyst target is $195.00 (-51.0%).
- Negative session, down 0.4%.
- Humana Inc. (HUM) moved -5.22% from $407.78 to $386.48 on 2026-07-16.
Weighing both sides, BestStocks' composite read of recent signals is roughly balanced, as the bull-versus-bear meter above shows. This is an educational summary of the bull and bear case, not investment advice.
Analyst price targets and ratings are FMP consensus figures as of Jul 21, 2026; other aggregators may differ. High and low targets show the range of estimates, not forecasts.
Previous notable changes for HUM
Frequently asked questions about HUM
Why did Humana Inc. (HUM) stock move?
HUM fell 0.4% to $398.25. No single company-specific catalyst was confirmed during the move window, and it looks technical.
How much did HUM stock fall?
HUM lost 0.44% ($1.75) versus the prior close of $400.00, last trading at $398.25 on 0.4× average volume.
When is Humana Inc.'s next earnings date?
HUM's next earnings report is estimated for 2026-07-29 — about 8 days away.
What is the analyst price target for HUM?
The consensus analyst price target for HUM is $343.06, about 13.9% below the current $398.25. Over the past 90 days, analysts recorded 2 upgrades, 24 maintains, and 0 downgrades.
How BestStocks tracks HUM
This page is generated automatically by BestStocks' change-detection system after its price and volume cleared HUM-specific materiality thresholds, triggering an evidence check. It draws on 9 tracked change events for HUM, cross-checked against the data sources listed below. Price, volume, and market-capitalization figures are the live intraday quote as of July 21, 2026 and refresh as new information is detected; for companies with multiple share classes, market-cap figures can differ by data source. Analyst price targets and ratings are FMP consensus. This is an educational summary of what changed and why — not personalized investment advice.